NIH-funded research Fellowship grant

How T cell activation is regulated by protein interactions and membrane structures

Official title: Mutual regulation between membrane rafts and protein condensates in T cell activation

Funded at University of Virginia · NIH-11094681 · Data updated 2026-11-12

This study is looking at how certain proteins help activate T cells, which are important for fighting infections and cancer, to better understand how they work and how this knowledge could help people with autoimmune diseases and immune system issues.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startMay 1, 2024
Project endApril 30, 2027
Funding year2025
Award (this year)$38,183
NIH project number5F31AI181453-02
Project IDNIH-11094681 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with autoimmune diseases or conditions affecting T cell function.

Less likely to help

Patients with non-autoimmune conditions or those not experiencing T cell-related issues may not benefit from this research.

What this research studies

This research investigates the mechanisms behind T cell activation, which is crucial for the immune response against infections and cancer. It focuses on the interactions between specific proteins and membrane structures that help regulate T cell signaling. By studying how these proteins form clusters and how they interact with lipid rafts in the cell membrane, the research aims to uncover new insights into T cell function and regulation. This could lead to a better understanding of autoimmune diseases and immunodeficiency disorders.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating autoimmune diseases and enhancing immune responses in patients.

How similar studies have gone: Other research has shown promising results in understanding T cell signaling and its implications for immune disorders, indicating that this approach has potential for success.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Chan, Sze Ham — University of Virginia
  • Study coordinator: Chan, Sze Ham

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.